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Volumetric Blood Flow in Transjugular
Intrahepatic Portosystemic Shunt 
Revision Using 3-Dimensional Doppler
Sonography
ransjugular intrahepatic portosystemic shunts (TIPSs) are
used in the management of portal hypertension and related
portal hypertensive complications such as variceal hemor-
rhage and ascites.1–6 Thrombosis or stenosis of the shunt is a prin-
cipal concern, as demonstrated by primary shunt patency rates:
25% to 66%, 5% to 42%, 21%, 13%, and 13% at years 1 through 5,
respectively.3,4,7–13 Primary shunt patency rates have been updated
by the introduction of covered stents, which show lower rates of
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Objectives—Three-dimensional (3D)/4-dimensional (4D) sonographic measurement
of blood volume flow in transjugular intrahepatic porto systemic shunt revision with
the intention of objective assessment of shunt patency.
Methods—A total of 17 patients were recruited (12 male and 5 female; mean age, 55 years;
range, 30–69 years). An ultrasound system equipped with a 2.0–5.0-MHz probe was
used to acquire multivolume 3D/4D color Doppler data sets to assess prerevision and
postrevision shunt volume flow. Volume flow was computed offline based on the prin-
ciple of surface integration of Doppler-measured velocity vectors in a lateral-eleva-
tional c-surface positioned at the color flow focal depth (range, 8.0–11.5 cm). Volume
flow was compared to routine measurements of the prerevision and postrevision por-
tosystemic pressure gradient. Prerevision volume flow was compared with the outcome
to determine whether a flow threshold for revision could be defined.
Results—Linear regression of data from revised transjugular intrahepatic portosystemic
shunt cases showed an inverse correlation between the mean-normalized change in
prerevision and postrevision shunt volume flow and the mean-normalized change in the
prerevision and postrevision portosystemic pressure gradient (r2 = 0.51; P = .020).
Increased shunt blood flow corresponded to a decreased pressure gradient. Comparison
of prerevision flows showed preliminary threshold development at 1534 mL/min,
below which a shunt revision may be recommended (P = .21; area under the receiver
operating characteristic curve = 0.78).
Conclusions—Shunt volume flow measurement with 3D/4D Doppler sonography
provides a potential alternative to standard pulsed wave Doppler metrics as an indicator
of shunt function and predictor of revision.
Key Words—color flow; Doppler sonography; portal hypertension; power Doppler
sonography; transjugular intrahepatic portosystemic shunt revision; vascular ultra-
sound; volume flow
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failure than uncovered stents. A recent study by Bureau et
al14 compared outcomes in 39 patients with covered stents
and 41 patients with uncovered stents. Covered-stent
shunt dysfunction was shown in 13% of patients based on
the criteria of greater than 50% stenosis or a portosystemic
pressure gradient of greater than 12 mm Hg after a median
follow-up of 300 days. Other investigators have shown cov-
ered stent dysfunction rates between 8% and 20% at 1
year.15–19 However, approximately 20% of TIPS proce-
dures in the United States still use uncovered stents.20
Interventional revision prolongs patency and if per-
formed before complete occlusion yields increased primary-
assisted patency rates: 80% to 85%, 61% to 79%, 46% to
87%, 42%, and 36% at years 1 through 5, respectively.4,7–11,13
Therefore, shunt dysfunction must be identified promptly
and managed appropriately to define a therapeutic window
for revision.
Transjugular intrahepatic portosystemic shunt screen-
ing identifies cases that require revision, but current sono-
graphic assessment techniques have variable sensitivity and
specificity, and venography, the reference standard for
detecting shunt dysfunction, is invasive and unsuitable for
routine use.4,6 Doppler sonography is the primary imaging
modality used for TIPS patency screening.4,6 Although sev-
eral flow velocity criteria for defining TIPS failure have
been proposed in the literature, each has proponents and
detractors, and a nonuniform association exists between
flow velocity and shunt patency.4,6,21–27 Literature has
also demonstrated a poor correlation (r = –0.11) between
flow velocity and the portosystemic pressure gradient.28
Variability in the flow velocity estimate is motivated by
several objective and subjective factors: resistance of the
overall flow path, Doppler angle, cylindrically asymmetric
flow profile, internal aliasing, and shunt morphologic fea-
tures such as overlapping stents and curves in the shunt.
Individually or collectively, these factors can yield velocity
fluctuation along the length of the shunt.
Volume flow is an alternative metric to flow velocity
that may be used to assess shunt patency.29–31 In a TIPS,
since there is only one inflow and one outflow, volume flow
is conserved and thus equivalent everywhere along the path
of the shunt. Therefore, volume flow provides a potentially
robust metric for evaluating shunt patency.
The proposed 3-dimensional (3D)/4-dimensional
(4D) volume flow measurement technique—based on
surface integration of Doppler-measured velocity vectors—
is noninvasive, objective, and independent of all traditional
pulsed wave Doppler assumptions.32–37 Measurement of
TIPS volume flow is demonstrated in patients undergoing
revision and compared to standard measurements of the
revision portosystemic pressure gradient. Volume flow
measurements are also evaluated on the basis of prerevi-
sion shunt flow and outcome to determine whether a flow
threshold for revision could be defined. The hypothesis
of this study was that the proposed 3D/4D sonographic
volume flow measurement technique provides straight-
forward, objective, and reliable assessment of shunt flow
as a means for determining patency and defining a thera-
peutic strategy for revision.
Materials and Methods
Clinical and Experimental Procedures
A total of 17 patients admitted for TIPS revision were
consecutively enrolled from the University of Michigan
Medical Center’s interventional radiology service in this
prospective study. This patient population was selected
because prerevision and postrevision portosystemic pressure
gradient measurements would be available as a reference
standard for comparison with the volume flow estimates.
Patient demographics and clinical characteristics are sum-
marized in Tables 1 and 2. Table 2 shows a total prospec-
tive patient count of 19 because patient 3 was scanned
3 times on separate hospital visits (3A, 3B, and 3C).
Patients included in the study were referred to interven-
tional radiology with clinical signs of shunt dysfunction
(reaccumulation of ascites and hepatic hydrothorax) or
sonographic findings showing a temporal change in shunt
velocities or flow patterns. Each patient provided fully
informed written consent to an Institutional Review
Board– approved protocol involving transcutaneous
measurement of blood volume flow using sonography.
Patients unwilling to sign consent were excluded from
the study.
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Table 1. Patient Demographics
Characteristic Value
Male/female, n 12/5
Mean age (range), y 55 (30–69)
Etiology of cirrhosis, n
Alcohol 4
Hepatitis C 3
Sclerosing cholangitis 1
Nonalcoholic steatohepatitis/cryptogenic 6
Budd-Chiari 1
Mesenteric thrombosis 1
Congenital hepatic fibrosis 1
Indication, n
Varices 6
Ascites 10
Both 1
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From the 17-patient population, a total of 20 TIPS
cases were obtained because patient 5 had 2 TIPSs and
patient 3 was scanned 3 times on separate hospital visits.
The 20 cases can be categorized as follows: 12 TIPSs revised,
3 TIPSs not revised, and 5 TIPS cases omitted. Cases were
omitted for one of the following reasons, none of which
was due to the surface integration of Doppler-measured
velocity vector volume flow technique, but to unrelated
factors: (1) data acquisition error, (2) inadequate color
flow image quality, (3) high body mass index (ie, poor
acoustic access), and (4) fully thrombosed shunt (ie, lack
of a prerevision pressure gradient). These cases are marked
with an asterisk in Table 2. In addition, 2 revised cases
(patients 5 and 11) were excluded, as described in “Results.”
Shunt volume flow was assessed twice for each patient
with one flow measurement immediately before revision
(<2 hours) and one flow measurement immediately
subsequent to revision (<2 hours). All patients received
nothing by mouth for at least 6 hours before prerevision
volume flow measurement and maintained receiving noth-
ing by mouth for the postrevision scan.
Transjugular intrahepatic portosystemic shunt revision
followed the standard interventional radiology protocol at
the University of Michigan Medical Center (P.M.N., with
11 years of experience). The decision for angioplasty was
based on venographically visible stenosis. Stents were
dilated with a 4-cm-long balloon equal in diameter to the
original stent. Viatorr stents (Gore Medical, Flagstaff, AZ)
were dilated to 10 mm. Angioplasty was followed by stent
revision if venographic success was not achieved. A peak
systolic gradient between the right portal vein and right
atrium of greater than 12 mm Hg defined TIPS dysfunction.
Venography was performed in all patients to document the
stent luminal caliber, flow reversal in the portal circulation,
and antegrade flow in hepatic portal venous branches.
Pressure measurements were made under quiet tidal respi-
ration and averaged over 20 seconds.
A LOGIQ 9 ultrasound system (GE Healthcare, 
Milwaukee, WI) equipped with a 2.0–5.0-MHz probe
(4D3CL) was used to acquire multivolume 4D (near real-
time 3D) color Doppler data sets. Each multivolume data set
consisted of 30 image volumes acquired sequentially at a rate
of 1 volume every 10 seconds. This sequence corresponded
to an acquisition rate of 0.1 Hz, although the acquisitions
were not continuous. Patients held their breath during a vol-
ume acquisition and breathed between acquisitions. There
was also a time delay for the 3D reconstruction between
acquisitions. Since TIPS flow can be respiratory phase
dependent,38 patients were instructed to simply stop breath-
ing with no bias toward inspiration or expiration. Multi-
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Pinter et al—Volumetric Blood Flow in TIPS Revision Using 3D Doppler Sonography
Table 2. Patient Clinical Characteristics
Time After Time After Clinical Morphologic Abnormal 
TIPS Most Recent Stent Indication Indication Sonographic 
Patient Creation, mo Revision, mo Type for Revision for Revision Findingsa Revision Type
1* 68 62 VSG Asymptomatic None Yes None
2* 1 VSG Refractory ascites None Yes None
3 (3A) 17 6 VSG Refractory ascites Stenosis Yes Balloon angioplasty
4 143 BMS Asymptomatic Stenosis Yes Balloon angioplasty
5 60 VSG Refractory ascites Occlusion Yes Balloon angioplasty
6* 27 VSG Refractory ascites None Yes None
7* 1 BMS Refractory ascites Occlusion Yes Stent graft implantation
8* 20 6 VSG Refractory ascites Occlusion Yes Bare stent implantation
9 24 VSG Refractory ascites Stenosis No Balloon angioplasty
10 24 VSG Refractory ascites Stenosis Yes Bare stent implantation
11 112 104 BMS Refractory ascites Stenosis Yes Balloon angioplasty
12 12 VSG Refractory ascites Stenosis Yes Bare stent implantation
13 126 81 VSG Asymptomatic None Yes None
14 42 14 VSG Refractory ascites Stenosis Yes Balloon angioplasty
15 (3B) 23 5 VSG Refractory ascites Stenosis Yes Balloon angioplasty
16 166 VSG Asymptomatic None Yes Balloon angioplasty
17 12 VSG Refractory ascites None No Balloon angioplasty
18 12 VSG Asymptomatic None Yes None
19 (3C) 28 5 VSG Refractory ascites Stenosis Yes Bare stent
BMS indicates bare metal stent; 3A, 3B, and 3C, multiple studies in patient 3; and VSG, Viatorr stent-graft.
aAbnormal sonographic findings consisted of 1 or more of the following criteria: (1) changes in baseline velocities, (2) reversal of flow in the
left or right portal vein away from the TIPS, and (3) absence of flow in the TIPS.
*Omitted for reasons described in “Materials and Methods.”
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 volume data sets were processed offline by exporting
LOGIQ 9 4D duplex mode raw DICOM data (Digital
Imaging and Communications in Medicine) (Medical
Imaging & Technology Alliance, Arlington, VA) and the
associated scanner acquisition settings for prospective
analysis.
Figure 1 illustrates the imaging geometry required for
the proposed volume flow technique. The position and tilt
angle of the probe must be adjusted to visualize the shunt
cross section in the lateral-elevational imaging surface.
Although the shunt is required to intersect the c-surface in
cross section (Figure 1A), the volume flow method is inde-
pendent of the angle at which the shunt intersects the c-sur-
face. For example, the shunt cross section can vary from
circular to ellipsoidal (Figure 1B), and each geometry will
yield an identical volume flow estimate. The c-surface was
typically positioned near the middle of the stent and as close
as possible to the color flow focus, which ranged in depth
from 8.0 to 11.5 cm (14.5 cm in 1 case) depending on the
position of the shunt, patient’s body mass index, and pres-
ence of overlying ascites. For the 8.0- to 11.5-cm depth range,
the c-surface consisted of a lateral pixel size range of 1.2 to 1.5
mm and an elevational pixel size range of 1.5 to 2.0 mm.
Volume flow for each multivolume data set was com-
puted offline (S.Z.P.) using custom algorithms written in
MATLAB (The MathWorks, Natick, MA), which imple-
mented the principle of surface integration of Doppler-
measured velocity vectors.32,34 The computation c-surface
was defined at, or near, the color flow focus of the acquired
3D volume. Power Doppler data were used as a correction
factor to compensate for partial volume effects by weight-
ing flow estimates in reference to pixels containing 100%
blood.33,35,36 Principles of the volume flow computation
method are described later in this section.
For each 30-volume data set, volume flow was com-
puted on a volume-by-volume basis to yield 30 individual
estimates that were subsequently averaged to produce the
overall flow in the shunt. Volume-by-volume flow compu-
tation is advantageous because it allows for shunt motion
(respiration, bulk motion, and probe movement) within
the scanning volume of interest between acquisitions. In
some data sets, however, a few individual volumes were
discarded due to movement during an acquisition.
Two segmentation methods were used to exclude
unrelated vasculature and local color flow artifacts from
the c-surface. First, directional criteria were used to auto-
matically differentiate shunt flow from any adjacent arterial
flow. Second, manual segmentation (S.Z.P.) placed a
broad outline around the shunt and excluded extraneous
vessels and artifacts in the volume of interest.
Prerevision and postrevision shunt volume flow meas-
urements made by sonography were compared to routine
prerevision and postrevision portosystemic pressure
gradients measured via a catheter using an electronic
manometer. The volume flow metric was defined as the
mean-normalized change in prerevision and postrevision
shunt volume flow (ΔQ/Q avg), and the portosystemic
pressure gradient metric was defined as the mean-normalized
Pinter et al—Volumetric Blood Flow in TIPS Revision Using 3D Doppler Sonography
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Figure 1.  A, Imaging geometry required for the proposed volume flow measurement technique. The probe is oriented such that the TIPS intersects
the c-surface (lateral-elevational surface) in cross section. B, The angle of c-surface intersection is an independent variable. The TIPS can inter-
sect the c-surface at angles that yield circular (θ1) to ellipsoidal (θ2 and θ3) geometries, and all cases would yield an identical volume flow estimate.
A B
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change in the prerevision and postrevision portosys-
temic pressure gradient (ΔP/Pavg). Data were also evalu-
ated on the basis of prerevision shunt volume flow and the
outcome to determine whether a flow threshold for revi-
sion could be defined. Clinical outcomes and portosys-
temic pressure gradient measurements were abstracted
from the medical records of the recruited patients.
Statistical Methods
Linear regression analysis was performed between the vol-
ume flow and portosystemic pressure gradient metrics and
plotted with a 95% confidence interval. The ΔQ/Q avg
volume flow metric was reported as mean and standard
deviation, where the standard deviation was computed by
using the standard rules of error propagation for an up to
30-volume data set. Groups were compared by the t test for
independent samples and reported with 2-tailed P values.
Individual groups were reported as mean and standard
error. All statistical analyses were performed with Prism 5
software (GraphPad, La Jolla, CA). P < .05 was considered
a statistically significant difference.
Power-Weighted Surface Integration of Doppler-
Measured Velocity Vectors
Surface integration of Doppler-measured velocity vectors
is based on the Gauss divergence theorem. Volume flow,
Q, can be defined as the total flux through a surface, S, that
completely transects a vessel:
(1) ,
where v is the Doppler-measured velocity vector, and A is
the surface area element. The scanning geometry illus-
trated in Figure 1 ensures that normality is maintained
between the local velocity vector and the local surface area
element; therefore, the dot product in Equation 1 simpli-
fies to a multiplication. With this simplification and in the
discrete case, mean volume flow through a c-surface can
be redefined as:
(2) ,
where vi is the mean local Doppler-measured velocity
vector for a single pixel i; Ai is the local surface area of the
corresponding pixel i; and i is taken over all pixels in the
c-surface. The velocity vector and surface area element
must be normal (ie, perpendicular) for the application of
Equation 2.
Figure 2 illustrates the principle of power-weighted
surface integration of Doppler-measured velocity vectors
for a single vessel with an ellipsoidal cross section in the c-
surface. For color flow pixels that fully intersect the vessel
(6 dark blue pixels in Figure 2), volumetric flow through
the pixel c-surface can be computed by using Equation 2.
However, a subset of color flow pixels in Figure 2 only par-
tially intersect the vessel (14 light blue pixels in Figure 2)
and thus contribute only partially to the flow estimate.
The extent of partial contribution is determined by the
power Doppler signal, which is assumed as directly pro-
portional to the number of scattering red blood cells.33
A weighting factor, w, computed in reference to the power
in pixels containing 100% blood, reflects the fraction of
blood intersected by the pixel and is applied to the volume
flow estimate as follows:
(3) ,
where 0 ≤ wi ≤ 1, and i is taken over all pixels in the c-surface.
For example, wi = 0.5 indicates a pixel area that contains, or
intersects, only 50% blood. Power weighting automatically
identifies the vessel boundary because the weighting factor
is 0 outside the vessel. Only a broad vessel outline is required
to exclude extraneous flow and artifacts.
The following describes the steps for determining the
weighting factor. A histogram is generated using Doppler
power values corresponding to each velocity measurement
J Ultrasound Med 2015; 34:257–266 261
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Figure 2. Power-weighted surface integration of Doppler-measured
velocity vectors illustrated on a vessel with an ellipsoidal cross section
(black outline) in the lateral-elevational imaging surface (c-surface).
Each color flow pixel that intersects the vessel possesses a Doppler-
measured axial velocity vector that is normal for the area element. Axial
velocity vectors are indicated. Color flow pixels positioned inside the
vessel correspond to 100% blood; those outside the vessel correspond
to 0% blood; and those partially inside the vessel correspond to values
between 0% and 100% blood. Integration of flow over the c-surface
yields volume flow through the shunt.
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on the c-surface. The Doppler power value that corre-
sponds to the peak in the histogram is selected automati-
cally and defined as pmax. A power threshold, pthres , is chosen
as 90% of pmax and identifies the minimum power value of
those pixels positioned fully inside the vessel. This power
threshold represents the minimum power value of 100%
blood. Color flow pixels associated with Doppler power
values greater than or equal to pthres are set to possess a
weighting factor w = 1. The remaining Doppler power
values, all of which are greater than or equal to 0 but less
than pthres , are linearly scaled to possess a weighting factor
between 0 ≤ w < 1. The weighting factor is assigned irre-
spective of the color pixel spatial position. Evaluation of
Equation 3 yields the total flow through the shunt while
correcting for the partial volume effect.
Results
Figure 3 shows representative axial-lateral (Figure 3A) and
elevational-lateral (Figure 3B) color flow images of a single
volumetric TIPS scan for patient 4 after revision. Shunt
volume flow can be assessed by the proposed method as
long as the elevational-lateral surface, or constant depth
c-surface, can be positioned to fully intersect the shunt in
cross section, as shown in Figure 3B. This cross-sectional
orientation was achieved for each recruited patient and
demonstrates the broad applicability of the method.
Figure 4 shows the relationship between the ΔQ/Q avg
volume flow metric and the ΔP/Pavg portosystemic pres-
sure gradient metric. The 12 of 20 TIPS cases for which a
revision was performed are included in the linear regression
of Figure 4A, which demonstrates an inverse correlation
between TIPS volume flow and the portosystemic pressure
gradient. An increase in shunt volume flow corresponds to
a decrease in the portosystemic pressure gradient.
An updated linear regression is presented in Figure
4B, in which 2 specific revised cases were excluded from
the data set. Patient 5 (*) had 2 TIPSs, of which 1 shunt
was revised and the other was not revised. After revision,
increased flow was observed in both shunts; therefore, the
volume flow and portosystemic pressure gradient metrics
could not be reliably computed. Given that the 2 shunts are
components in a complex parallel vascular flow circuit,39
the flow path through a 2-TIPS structure is not clearly
understood. Patient 11 (†) had an atypical breathing
pattern that was required to observe flow within the shunt
lumen. Given the circumstances described, these 2 cases can
be justifiably excluded, and the updated linear regression
shows a stronger correlation between the volume flow and
portosystemic pressure gradient metrics.
Figure 5 provides a prerevision TIPS volume flow
comparison between cases not revised or revised with an
unchanged portosystemic pressure gradient and cases
revised with a decreased portosystemic pressure gradient.
All 15 TIPS cases (12 revised and 3 not revised) are included
in the comparison of Figure 5A. An updated comparison is
presented in Figure 5B, in which the same 2 cases (patients 5
and 11), as described above, were excluded from the data set.
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Figure 3. Color flow images of a TIPS in axial-lateral (A) and elevational-
lateral (c-surface; B) views for patient 4 after revision. A and B coincide
at the center point marked in each view. The color flow focus depth is
11.25 cm and is positioned at the axial center of A. The elevational-lateral
surface intersects the shunt at a depth of 11.25 cm. B-mode image stri-
ations in A represent the stent mesh boundary. The color bar indicates
velocity in centimeters per second.
A
B
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Overall, 3 data points are excluded from Figure 5B because
patient 5 had 2 TIPSs, and both the revised (*) and non-
revised (+) prerevision flow measurements were omitted.
Comparison of prerevision flow shows a developing
threshold below which a TIPS revision may be recom-
mended. A volume flow threshold of 1534 mL/min yields
sensitivity of 66.7% and specificity of 100%. A less conser-
vative volume flow threshold of 1873 mL/min yields sen-
sitivity of 66.7% and specificity of 66.7%. The abilities of
shunt volume flow to discriminate between individuals
requiring a revision and those not requiring a revision are 73%
(area under the receiver operating characteristic curve = 0.73)
and 78% (area under the receiver operating characteristic
curve = 0.78) for Figure 5, A and B, respectively.
Discussion
Doppler sonography has traditionally been the primary mode
for TIPS evaluation and is generally accepted as an excellent
method for detecting complete shunt occlusion.4,21,22,24–26
J Ultrasound Med 2015; 34:257–266 263
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Figure 4. Relationship between the mean-normalized change in prerevision and postrevision shunt volume flow (ΔQ/Qavg) and the mean-normalized
change in the prerevision and postrevision portosystemic pressure gradient (ΔP/Pavg) for all TIPS cases for which a revision was performed (A) and
excluding 2 revised TIPS cases (* and †; B) for reasons described in “Results.” Solid lines represent the linear regression, and dashed lines represent
95% confidence intervals. Error bars indicate standard deviation in the flow metric for an up to 30-volume data set.
A B
Figure 5. Prerevision TIPS volume flow comparison between cases not revised or revised with an unchanged portosystemic pressure gradient (PSPG)
and cases revised with a decreased portosystemic pressure gradient for all TIPS cases (A) and excluding 2 TIPS cases (ie, 3 data points; *, +, and †; B),
for reasons described in “Results.” Error bars indicate standard error of the mean.
A B
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However, a completely occluded shunt is typically more dif-
ficult to revise, so a failing TIPS must be identified promptly
and revised before this time. Current Doppler methods
have demonstrated an opportunity for improvement.
Given the complexity in the parallel vascular flow
circuit,39 shunt flow velocity depends on several factors 
in the overall circuit, and one can conceive of situations in
which local blood flow velocities can increase, decrease, or
remain unchanged in a failing TIPS. In the presence of a
relative stenosis, the shunt cross-sectional area will decrease.
If the TIPS behaves identically to a blood vessel that
supplies an autoregulating organ, flow velocity at the
stenosis would increase to maintain constant volume flow
(this principle is used to estimate stenoses in carotid and
renal Doppler examinations). However, a TIPS does not
autoregulate and is simply intended to function as a low-
resistance short circuit that diverts blood flow away from a
cirrhotic liver or varices. Therefore, in a TIPS, a stenosis
produces an increase in local flow resistance and may cause
diversion of blood flow to other parts of the vascular flow
circuit. If the decrease in blood flow equally compensates
for the decrease in the cross-sectional area, the local flow
velocity will remain unchanged even though a TIPS
stenosis exists. In addition, the flow velocity can vary along
the path of the shunt and even fluctuate with time.4,40
Variability in the flow velocity estimate is apparent in
recent studies that have shown unreliable Doppler meas-
urements when assessing TIPS function.27,41,42 In fact,
updated recommended guidelines for evaluating TIPS
function have reverted to recurrence of the problem for which
the TIPS was originally placed as grounds for revision.43
In contrast, changes in volume flow are straightforward to
interpret. For example, if TIPS flow decreases and cardiac
output is presumed unchanged, blood must be shunted
elsewhere such as varices, which suggests a TIPS stenosis.
In this case, decreased TIPS flow would be a realistic
measure of TIPS failure.
Assessment of TIPS flow and function has been
demonstrated by using a 3D/4D sonographic volume flow
technique that provides an alternative objective measure
of shunt patency and overcomes many limitations associ-
ated with traditional pulsed wave Doppler imaging.
Traditional pulsed wave Doppler imaging is unable to
reliably estimate volume flow due to subjective measure-
ment of the vessel diameter, an assumption of circular shunt
geometry, subjective Doppler angle correction, and an
assumption of a cylindrically symmetric flow profile.
Volume flow measurements with the proposed method are
independent of the vessel geometry, angle, and flow profile.
Bench-top determinations of accuracy with the proposed
method showed an error within 5% achieved after acqui-
sition of 15 volumes under pulsatile flow conditions.36
Volume flow is expected to be a more robust metric for
patency than flow velocity because flow must be conserved
along the path of the shunt; therefore, a measurement can
be made anywhere along the TIPS.
Results of this preliminary study show an inverse cor-
relation between the mean-normalized change in prere-
vision and postrevision shunt volume flow and the mean-
normalized change in the prerevision and postrevision por-
tosystemic pressure gradient, which indicates that an
increase in shunt volume flow corresponds to a decrease
in the portosystemic pressure gradient (r2 = 0.51; P = .020).
Therefore, a relative change in shunt blood flow appears
to be an acceptable surrogate for a change in the shunt
portosystemic pressure gradient for TIPS revision cases.
Variability in the flow metric (error bars in Figure 4) is pre-
sumed to be due to biological variability in shunt flow.
Blood flow has an advantage over pressure in that one
can perform the measurement in a standard diagnostic
environment. A feasible clinical implementation would
involve measurement of volume flow immediately after a
successful TIPS revision: ie, an achieved portosystemic
pressure gradient of less than 12 mm Hg. Screening would
then involve straightforward quantitative comparison of
subsequent volume flow measurements to the baseline
value to assess TIPS function.
Transjugular intrahepatic portosystemic shunt volume
flow measurements with the proposed 3D/4D method
are in line with those presented in the literature.29–31
Comparison of prerevision shunt flow for all 15 TIPS cases
shows a preliminary threshold developing at 1534 mL/min,
below which a TIPS may be recommended for revision
depending on complementary clinical criteria. All normal
TIPS cases in this study had flow above this threshold.
The group comparison in Figure 5 illustrates promise for
the proposed method given published sensitivities for stan-
dard Doppler methods (eg, 35%).27 For a representative
example, consider the results from patient 9, whose pre-
revision flow was measured as 1910 ± 298.9 mL/min
(mean ± SD), which suggests that a revision may be
unnecessary. On the basis of traditional criteria, this patient
was referred for revision. However, the postrevision por-
tosystemic pressure gradient was unchanged, and this out-
come was reflected in postrevision flow, which was
measured as 1938 ± 355.9 mL/min. Follow-up sonography
1 month after revision showed a patent TIPS. This patient
died of cardiac-related issues 5 months after revision.
An upper-bound threshold above which all TIPSs are
considered normal could not be defined from the prelim-
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inary results in this study. Figure 5B shows 3 false-negative
cases at the 1534-mL/min threshold defined above.
Identifying such an upper-bound threshold requires further
study with a larger patient population. A patient with TIPS
flow above the 1534-mL/min threshold will require addi-
tional clinical criteria to confirm normal TIPS function.
In contrast, TIPS flow below the threshold would by itself
suggest that a TIPS revision may be necessary. However,
initial measurements with the proposed volume flow
method should be used as a complementary or additive
clinical criterion.
Although the proposed method is independent of all
traditional pulsed wave Doppler assumptions, the operator
must still recognize the correct color/power gain and
Doppler pulse repetition frequency to avoid aliasing. In addi-
tion, the operator must ensure that the lateral-elevational
c-surface fully intersects the shunt in the cross-section.
Correct selection of the color/power gain and pulse repe-
tition frequency is necessary for any Doppler quantifica-
tion and is therefore not unique to the proposed method.
This study had a few limitations. First, 2 revised cases
were excluded from the linear regression analysis (Figure 4),
and 2 cases (ie, 3 data points) were excluded from the pre-
revision volume flow comparison (Figure 5). Reasons for
excluding these cases were justified due to a 2-TIPS struc-
ture and unusual contingencies in their data acquisition.
Fortunately, results from these cases were outside the
expected range; therefore, the resultant linear regression
showed a stronger correlation (r 2 = 0.51; Figure 4B).
Including these cases reduces the correlation, and although
the regression is less compelling, the correlation is still sig-
nificant (P = .036; Figure 4A).
Second, the total acquisition time for a complete color
Doppler data set consisting of 30 3D/4D image volumes
required approximately 6 to 10 minutes, with each trans-
ducer sweep requiring a breath hold. This was a technical
limitation because a mechanically swept 3D ultrasound
probe was used. However, 30 volumes were acquired because
this study was interested in estimating reproducibility. In a
clinical setting, an operator might be willing to make a meas-
urement consisting of fewer acquisitions. For example, 10
acquisitions might only require 2 to 3 minutes. Furthermore,
a 2D electronic ultrasound array can acquire 3D image
volumes more rapidly than a mechanically swept 3D probe,
and the acquisition of 30 image volumes could be completed
in seconds (ie, 1 or 2 breath holds).
Third, there were limitations with the study inclusion
criteria. Only patients scheduled for revision were recruited;
therefore, only 3 cases with nonrevised TIPSs were
enrolled in the study. Future studies intend to include addi-
tional control cases to help strengthen statistical conclu-
sions. In addition, study inclusion criteria should consider
the patient’s body mass index. Acoustic access to the TIPS
is limited in overweight patients, which causes an increased
imaging depth and reduced Doppler power at depth.
In conclusion, volume flow measurement in TIPS
cases using 3D/4D Doppler sonography provides a poten-
tial alternative to standard pulsed wave Doppler metrics
for evaluating shunt patency and identifying cases
requiring revision. With further refinements, volume
flow estimates can be incorporated as part of routine TIPS
screening and evaluation. Ultimately, volume flow meas-
urements could be applied to other vascular conditions,
such as portal hypertension in the liver and liver trans-
plants, to assess therapeutic outcomes.
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